Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP

Neurobiology of Disease

Volumn 28, Issue 3, 2007, Pages 304-315

  Talamagas, Argiris A ^a   Efthimiopoulos, Spiros ^b   Tsilibary, Effie C ^a   Figueiredo Pereira, Maria E ^c   Tzinia, Athina K ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alzheimer; Amyloid beta peptide; Amyloid precursor protein; Integrin; MMP 9; Secretase

Indexed keywords

ALPHA SECRETASE; ALPHA2BETA1 INTEGRIN RECEPTOR; ALPHA3BETA1 INTEGRIN RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN 695; AMYLOID PRECURSOR PROTEIN ALPHA; EDETIC ACID; GELATINASE B; GELATINASE INHIBITOR; INTEGRIN RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN PRECURSOR; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; UPREGULATION;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIBODIES; BIOLOGICAL TRANSPORT; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; MATRIX METALLOPROTEINASE 9; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 36249015501     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.07.016     Document Type: Article

References (53)

1. Agrez M., Gu X., Turton J., Meldrum C., Niu J., Antalis T., and Howard E.W. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. Int. J. Cancer 81 (1999) 90-97
2. Ahmad M., Takino T., Miyamori H., Yoshizaki T., Furukawa M., and Sato H. Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. J. Biochem. (Tokyo) 139 (2006) 517-526
3. Anderson J.P., Esch F.S., Keim P.S., Sambamurti K., Lieberburg I., and Robakis N.K. Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128 (1991) 126-128
4. Anderson S.S., Wu K., Nagase H., Stettler-Stevenson W.G., Kim Y., and Tsilibary E.C. Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhes. Commun. (1996) 89-101
5. Asahina M., Yoshiyama Y., and Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin. Neuropathol. 20 (2001) 60-63
6. Backstrom J.R., Miller C.A., and Tokes Z.A. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J. Neurochem. 58 (1992) 983-992
7. Backstrom J.R., Lim G.P., Cullen M.J., and Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 16 (1996) 7910-7919
8. Bourguignon L.Y., Gunja-Smith Z., Iida N., Zhu H.B., Young L.J., Muller W.J., and Cardiff R.D. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol. 176 (1998) 206-215
9. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
10. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., and Greengard P. Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3055-3059
11. Deb S., and Gottschall P.E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66 (1996) 1641-1647
12. Deb S., Wenjun Zhang J., and Gottschall P.E. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res. 970 (2003) 205-213
13. DiPersio C.M., Shao M., Di Costanzo L., Kreidberg J.A., and Hynes R.O. Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. J. Cell. Sci. 113 Pt 16 (2000) 2909-2921
14. Efthimiopoulos S., Felsenstein K.M., Sambamurti K., Robakis N.K., and Refolo L.M. Study of the phorbol ester effect on Alzheimer amyloid precursor processing: sequence requirements and involvement of a cholera toxin sensitive protein. J. Neurosci. Res. 38 (1994) 81-90
15. Eikelenboom P., Zhan S.S., Kamphorst W., van der Valk P., and Rozemuller J.M. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch. 424 (1994) 421-427
16. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., and Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248 (1990) 1122-1124
17. Estus S., Golde T.E., and Younkin S.G. Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives. Ann. N. Y. Acad. Sci. 674 (1992) 138-148
18. Fiore E., Fusco C., Romero P., and Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21 (2002) 5213-5223
19. Fridman R., Toth M., Pena D., and Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55 (1995) 2548-2555
20. Gervasi D.C., Raz A., Dehem M., Yang M., Kurkinen M., and Fridman R. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells. Biochem. Biophys. Res. Commun. 228 (1996) 530-538
21. Ghiso J., Rostagno A., Gardella J.E., Liem L., Gorevic P.D., and Frangione B. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, - RHDS -, that promotes cell adhesion. Biochem. J. 288 Pt 3 (1992) 1053-1059
22. Goldgaber D., Lerman M.I., McBride W.O., Saffiotti U., and Gajdusek D.C. Isolation, characterization, and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer's disease, Down's syndrome and aging. J. Neural Transm., Suppl. 24 (1987) 23-28
23. Gottschall P.E., and Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3 (1996) 69-75
24. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., and Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25 (2005) 6401-6408
25. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., and Teplow D.B. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
26. Hung A.Y., Haass C., Nitsch R.M., Qiu W.Q., Citron M., Wurtman R.J., Growdon J.H., and Selkoe D.J. Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268 (1993) 22959-22962
27. Kleifeld O., Kotra L.P., Gervasi D.C., Brown S., Bernardo M.M., Fridman R., Mobashery S., and Sagi I. X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. comparison with the latent and active forms of the enzyme. J. Biol. Chem. 276 (2001) 17125-17131
28. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., and Ishiura S. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343 Pt 2 (1999) 371-375
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
30. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3922-3927
31. Langholz O., Rockel D., Mauch C., Kozlowska E., Bank I., Krieg T., and Eckes B. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J. Cell Biol. 131 (1995) 1903-1915
32. Larjava H., Lyons J.G., Salo T., Makela M., Koivisto L., Birkedal-Hansen H., Akiyama S.K., Yamada K.M., and Heino J. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell. Physiol. 157 (1993) 190-200
33. Leake A., Morris C.M., and Whateley J. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci. Lett. 291 (2000) 201-203
34. Lorenzl S., Albers D.S., Relkin N., Ngyuen T., Hilgenberg S.L., Chirichigno J., Cudkowicz M.E., and Beal M.F. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int. 43 (2003) 191-196
35. Matter M.L., Zhang Z., Nordstedt C., and Ruoslahti E. The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. J. Cell Biol. 141 (1998) 1019-1030
36. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
37. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., and Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16 (1997) 2319-2332
38. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
39. Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D.L., and Quigley J.P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274 (1999) 13066-13076
40. Robakis N.K., Ramakrishna N., Wolfe G., and Wisniewski H.M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 4190-4194
41. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
42. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., and Oltersdorf T. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 7341-7345
43. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thal L.J., et al. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361 (1993) 260-263
44. Takahashi C., Sheng Z., Horan T.P., Kitayama H., Maki M., Hitomi K., Kitaura Y., Takai S., Sasahara R.M., Horimoto A., Ikawa Y., Ratzkin B.J., Arakawa T., and Noda M. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13221-13226
45. Tanaka M., Nanba D., Mori S., Shiba F., Ishiguro H., Yoshino K., Matsuura N., and Higashiyama S. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands. J. Biol. Chem. 279 (2004) 41950-41959
46. Toth M., Gervasi D.C., and Fridman R. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res. 57 (1997) 3159-3167
47. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
48. Tzinia A.K., Kitsiou P.V., Talamagas A.A., Georgopoulos A., and Tsilibary E.C. Effects of collagen IV on neuroblastoma cell matrix-related functions. Exp. Cell Res. 274 (2002) 169-177
49. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442
50. Yan P., Hu X., Song H., Yin K., Bateman R.J., Cirrito J.R., Xiao Q., Hsu F.F., Turk J.W., Xu J., Hsu C.Y., Holtzman D.M., and Lee J.M. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 281 (2006) 24566-24574
51. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., and Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26 (2006) 10939-10948
52. Yu Q., and Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13 (1999) 35-48
53. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14 (2000) 163-176